Clinical and patient reported outcomes in multiple sclerosis patients on disease modifying therapies

被引：0
|
作者：
Fernandes, L. [1 ]
Horton, M. [2 ]
Russell, M. [1 ]
Lily, O. [1 ]
Ford, H. L. [1 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, Leeds Ctr Neurosci, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds, W Yorkshire, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P812
引用
收藏
页码：417 / 418
页数：2
相关论文
共 50 条
  • [21] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [22] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [23] Disease-modifying therapies for multiple sclerosis
    John R. Corboy
    Douglas S. Goodin
    Elliot M. Frohman
    Current Treatment Options in Neurology, 2003, 5 (1) : 35 - 54
  • [24] Editorial: Disease modifying therapies in multiple sclerosis
    Bonavita, Simona
    Ghajarzadeh, Mahsa
    Lavorgna, Luigi
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [25] Analysis of Reported Deaths While Exposed to Disease-Modifying Therapies for Multiple Sclerosis
    Hooshmand, Sam
    Carlisle, Nicola
    Maynard, Michelle
    Hoffman, Leah
    Obeidat, Ahmed
    NEUROLOGY, 2020, 94 (15)
  • [26] The influence of disease-modifying therapies on neuropsychiatric outcomes in people with multiple sclerosis
    Freedman, David
    Oh, Jiwon
    Feinstein, Anthony
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1125 - 1125
  • [27] Factors Associated with Patient Preferences for Disease-Modifying Therapies in Multiple Sclerosis
    Hincapie, Ana L.
    Penm, Jonathan
    Burns, Craig F.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (08): : 822 - 830
  • [28] Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
    Alosaimi, Fahad D.
    AlMulhem, Alaa
    AlShalan, Hanan
    Alqazlan, Mohammad
    Aldaif, Abdulgader
    Kowgier, Matthew
    Balasundaram, Janooshsheya
    Sockalingam, Sanjeev
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 513 - 518
  • [29] Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies
    Grebenciucova, Elena
    Pruitt, Amy
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (11)
  • [30] A QUALITATIVE ASSESSMENT OF MULTIPLE SCLEROSIS PATIENTS' EXPERIENCES WITH DISEASE MODIFYING THERAPIES
    Thach, A.
    Brown, C.
    Herrera, V
    Sasane, R.
    VALUE IN HEALTH, 2016, 19 (03) : A65 - A65
12345